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and extracorporeal membrane oxygenation
Several articles have addressed important aspects of the
acute respiratory distress syndrome (ARDS) and its
treatment.
The incidence and outcome of ARDS in the era of
lung protective ventilation have been evaluated by Villar
and colleagues [1] in a 1-year prospective, multicenter,
observational study, under the acronym ALIEN (Acute
Lung Injury: Epidemiology and Natural History). The
study was conducted in 13 geographical Spanish areas,
which serve a population of 3.55 million of adults. A total
of 255 mechanically ventilated patients fulﬁlled the
ARDS deﬁnition, representing an incidence of 7.2/
100,000 population/year. Pneumonia and sepsis were the
most common causes of ARDS. At the time of meeting
ARDS criteria, mean PaO2/FiO2 was 114 ± 40 mmHg,
mean tidal volume was 7.2 ± 1.1 ml/kg predicted body
weight, mean plateau pressure was 26 ± 5 cmH2O, and
mean positive end-expiratory pressure (PEEP) was
9.3 ± 2.4 cmH2O. Overall ARDS intensive care unit
(ICU) and hospital mortality was 42.7% (95% CI
37.7–47.8) and 47.8% (95% CI 42.8–53.0), respectively,
suggesting that despite the use of lung protective venti-
lation, overall ICU and hospital mortality of ARDS
patients is still higher than 40%.
A couple of articles dealt with lung recruitment in
patients with ARDS. Dellamonica et al. [2] compared two
methods to evaluate PEEP-induced lung recruitment, one
based on the pressure–volume curve (considered as gold
standard) and the other based on the bedside end-expira-
tory lung volume (EELV) measurement using the nitrogen
washout/washin technique. PEEP-related strain was also
assessed at two levels of PEEP, low and high. Recruitment
assessed with the two techniques was well correlated. In
addition, the ratio between PEEP-induced lung volume
changes (DEELV) and functional residual capacity dif-
ferentiated high from low recruiters (110 vs. 55%). Strain
increased with PEEP and was larger in high recruiters.
Arnal et al. [3] assessed the dynamics of lung
recruitment and the hemodynamic changes during a
recruitment maneuver (sustained inﬂation at an airway
pressure of 40 cmH2O maintained for 30 s) in 50 patients
with ARDS. Most of the recruitment occurred during the
ﬁrst 10 s of the recruitment maneuver (mean time con-
stant for lung volume increase was 2.3 ± 1.3 s), while
arterial pressure decreased signiﬁcantly after 10 s. The
authors concluded that a duration of 10 s may be rec-
ommended for a sustained inﬂation to achieve sufﬁcient
lung recruitment while preventing hemodynamic com-
promise. This article was discussed in an editorial by
Marini [4]. The protective ventilatory strategy may fail in
the treatment of ARDS. Under this condition other ther-
apeutic strategies can be attempted.
Charron and colleagues [5] reported the characteristics
and prognosis of patients with severe lung injury (PaO2/
FiO2 \100 mmHg after 24–48 h of mechanical ventila-
tion) who are routinely ventilated in the prone position
using a low stretch ventilation strategy. In this mono-
center study, the authors provide data of 218 patients with
ARDS admitted between 1997 and 2009. Of these
patients, 57 (26%) were positioned prone because of a
PaO2/FiO2 \100 mmHg after 24–48 h of mechanical
ventilation. Prone sessions lasted 18 h/day, and 3.4 ± 1.1
sessions were required to obtain an FiO2 \60%. The
60-day mortality was 19%, and death occurred after
12 ± 5 days. Logistic regression analysis showed that
among the 218 patients, PP appeared to be protective with
an odds ratio of 0.35 [0.16–0.79]. It was concluded that
routine prone positioning is feasible in patients with a
PaO2/FiO2 \100 mmHg after 24–48 h, and suggest that
this strategy is protective and has a high survival rate.
In patients with ARDS, the combined use of high
frequency oscillation (HFO) and tracheal gas insufﬂation
(TGI) improves oxygenation versus standard HFO.
Mentzelopoulos and colleagues [6] hypothesized that
HFO ? TGI would reduce the amount of nonaerated lung
tissue in the dependent lung. Authors studied 15 patients
who had ARDS, and they were submitted to a whole-lung
CT scan after lung-protective conventional mechanical
ventilation (CMV) and after 45 min of HFO and 45 min
of HFO ? TGI. They found that HFO ? TGI versus
HFO and CMV resulted in a lower percentage of non-
aerated lung tissue (mean ± SD, 51.4 ± 5.1% vs.
60.0 ± 2.5%, and 62.1 ± 9.0%, respectively; p B 0.04);
this was due to HFO–TGI-induced recruitment of non-
aerated tissue in the dependent and nondependent lower
lung. In addition, HFO ? TGI signiﬁcantly improved
oxygenation versus HFO ? TGI. It was concluded that
HFO ? TGI improvement in oxygenation occurs through
a mechanism of recruitment of previously nonaerated
lower lung units.
The most severe cases of ARDS not responding to
conventional and advanced treatments need to be
approached through extracorporeal membrane oxygena-
tion (ECMO).
In a interesting study Nair and colleagues [7] describe
the technical challenges, efﬁcacy, complications, and
maternal and infant outcomes associated with ECMO for
severe ARDS in pregnant or postpartum patients during
the 2009 H1N1 pandemic. This retrospective observa-
tional study, conducted on seven tertiary hospitals in
Australia and New Zealand, studied 12 patients (7 preg-
nant and 5 postpartum). Their median [interquartile range
(IQR)] age was 29 (26–33) years; 6 (50%) were obese.
Two patients were initially treated with veno-arterial
(VA) ECMO. All others received veno-venous (VV)
ECMO with one or two drainage cannulae. ECMO cir-
cuit-related complications were rare, circuit change was
543needed in only two cases, and there was no sudden circuit
failure. Bleeding however was common, leading to large
volumes of packed red blood cell transfusions [median (IQR)
volume transfused was 3,499 (1,451–4,874) ml] and was the
main cause of death (three cases). Eight (66%) patients
survived to discharge. The survival rate of infants whose
mothers received ECMO was 71%, and surviving infants
were discharged home with no sequelae. It was concluded
that ECMO is effective, with outcomes comparable to those
of non-pregnant patients and acceptable infant outcomes.
Another interesting study [8] described the develop-
ment and results of a retrieval program developed in New
South Wales (NSW), Australia, to provide ECMO for the
safe transport of adults with severe, acute respiratory or
cardiac failure, from 1 March 2007 to 1 June 2010. Forty
adult patients were retrieved on ECMO support (median
age 34 years). The indications for retrieval were respira-
tory in 38 patients (of whom 16 were conﬁrmed or
suspected H1N1 cases) and cardiac in two patients. Two
other patients died after referral but before ECMO support
could be established.
Patients were transported by road (65%), medical
retrieval jet (25%) and helicopter (10%). Thirty-four
patients (85%) survived to hospital discharge. There were
no deaths or major morbidity associated with these ret-
rievals. It was concluded that severe respiratory failure,
which was considered to preclude conventional ventila-
tion for safe transfer to tertiary centers, was managed by
an ECMO referral and retrieval program in NSW and had
a high rate of survival. This program also enhanced the
capacity of the state to respond to a surge in demand for
ECMO support due to the H1N1 epidemic.
A multicenter Italian study [9] reported the organization
and results of a national ECMO network (ECMOnet) that
wassetupinviewoftheexpected2009inﬂuenzaA(H1N1)
pandemic. The network consisted of 14 ICUs with ECMO
capability and was set up to centralize all severe ARDS
patients to the ECMOnet centers assuring safe transfer.
Between August 2009 and March 2010, 153 critically ill
ARDS patients (53% referred from other hospitals) were
admitted to the ECMOnet ICU with suspected H1N1. Sixty
patients received ECMO according to ECMOnet criteria
(and 28 were transferred while on ECMO). Survival to
hospital discharge in patients receiving ECMO was 68%.
Thelengthofmechanicalventilationprior toECMO wasan
independent predictor of mortality. It was concluded that a
network organization based on preemptive patient central-
ization allowed a high survival rate and provided effective
and safe referral of patients.
Weaning
Patient-ventilator interaction during pressure support
ventilation (PSV) and proportional assist ventilation plus
[PAV?] were compared in a physiological study
involving 11 patients difﬁcult to wean [10].
During three consecutive trials [a ﬁrst trial of PSV
(PSV1), followed by PAV?, followed by a second PSV
trial (PSV2), with the same settings as PSV1], patients’
mechanical and respiratory patterns were evaluated.
Compared to PAV?, during PSV trials, the mechanical
inspiratory time [Ti(ﬂow)] was signiﬁcantly longer than
patient inspiratory time [Ti(pat)] (p\0.05); Ti(pat)
showed a prolongation between PSV1 and PAV?, and
PAV? signiﬁcantly reduced expiratory trigger delays
[delay(trexp)] (p\0.001).
The portion of tidal volume (VT) delivered in phase
with Ti(pat) [VT(pat)/VT(mecc)] was signiﬁcantly higher
during PAV? (p\0.01). The time of synchrony was
signiﬁcantly longer during PAV? than during PSV
(p\0.001). During PSV, 5 patients out of 11 showed an
asynchrony index (AI) greater than 10%, whereas the AI
was nil during PAV?. The authors concluded that PAV?
improves patient–ventilator interaction, signiﬁcantly
reducing the incidence of end-expiratory asynchrony and
increasing the time of synchrony.
Roze ´ et al. [11] evaluated a method for setting neu-
rally adjusted ventilatory assist (NAVA) during weaning,
with the NAVA level adjusted to obtain 60% of the
maximal diaphragmatic electrical activity (EAdi) mea-
sured during a spontaneous breathing trial (SBT). This
method proved to be feasible and well tolerated, allowing
for a progressive reduction of NAVA level during
weaning.
A second study [12] compared the effect of NAVA
and PSV on patient–ventilator interaction in 22 intubated
patients (COPD 36%). Patient–machine synchrony was
better with NAVA, as demonstrated by the lower number
of asynchronies per minute and the reduction in the
number of patients with asynchrony index [10%.
Improvement concerned particularly the inspiratory trig-
ger delay, ineffective efforts, and premature and late
cycling off. Finally, Tuchscherer et al. [13] assessed the
feasibility of a prolonged application of NAVA in patients
with critical illness-associated polyneuromyopathy. As
compared with healthy subjects, these patients showed a
prolonged phrenic nerve latency and a decreased dia-
phragm compound muscle action potential. Nevertheless,
NAVA could be applied in 13/15 patients for up to
3 days, with stable breathing pattern, hemodynamics and
gas exchange while preserving respiratory drive.
Two articles dealt with the prediction of weaning
outcome in mechanically ventilated patients. Zapata et al.
[14] evaluated the ability of B-type natriuretic peptides
(BNP) to predict and diagnose weaning failure from
cardiac origin. Thirty-two out of 100 patients failed a
SBT, 12 because of heart failure and 20 because of
respiratory failure. BNP and NT-proBNP were higher
before SBT and increased signiﬁcantly during SBT in
patients failing because of heart failure. BNP performed
544better than NT-proBNP for prediction and diagnosis of
weaning failure from cardiac origin.
Sellares et al. [15] compared clinical characteristics
and outcomes of patients with simple, difﬁcult and pro-
longed weaning, and assessed predictors for prolonged
weaning and survival in 181 mechanically ventilated
patients. Patients with simple (43%) and difﬁcult (39%)
weaning had similar characteristics and outcomes, while
those with prolonged weaning (18%) had a higher inci-
dence of COPD, more complications and worst outcomes.
Heart rate C105/min and PaCO2 C54 mmHg during SBT
predicted a prolonged weaning. In addition, reintubation
and hypercapnia during SBT independently predicted a
decreased 90-day survival. These ﬁndings were com-
mented on in the editorial by Laghi [16].
When the weaning fails patients may need to be tra-
cheotomized. Fikkers and colleagues [17] in a prospective
randomized clinical trial involving 120 patients, com-
pared two techniques of percutaneous tracheostomy: the
guide wire dilating forceps (GWDF) and the single step
dilatational tracheostomy (SSDT) technique. The early
and late outcomes were analyzed. Sixty patients in each
group were followed for up to 3 months after decannu-
lation. Most of the reported complications in both groups
were minor (58.3% in the GWDF group and 61.7% in the
SSDT group). A trend was found towards an higher per-
centage of major perioperative complications in the
GWDF group in comparison to the SSDT group [10.0 vs.
1.7% (p = 0.06)], with a comparable long-term outcome.
Mechanical ventilation
Gas conditioning
Zanella et al. [18] compared leakage of ﬂuid across the
cuff of different endotracheal tubes in a laboratory bench
study. A major ﬁnding was that the double-layer guayule
latex cuff prevented leakage at tested PEEP levels, from 0
to 15 cmH2O. The other tubes, cylindrical and conical
PVC cuffs as well as polyurethane cuffs did not prevent
leakage at zero PEEP, whereas with higher PEEP levels
leakage decreased and was absent at the highest PEEP
level.
Gas conditioning during mechanical ventilation is an
important problem. Moran and colleagues [19] compared
the effects of an active heated humidiﬁer (HH) and pas-
sive heat and moisture exchangers (HME) on
endotracheal tube resistance. Gas conditioning was per-
formed using the HH in 22 patients and the HME in
another 22. Patients were matched for endotracheal tube
diameter, days of mechanical ventilation, simpliﬁed acute
physiology score II (SAPS II) and ﬂuid balance. Used-
ETT (endo tracheal tube) resistance was measured
immediately after extubation. ETT diameters were similar
between the HH and HME groups (7.9 ± 0.4 vs.
7.9 ± 0.3 mm; p = 0.98), as well as days of mechanical
ventilation (11.3 ± 7.7 vs. 9.5 ± 4.5; p = 0.34), SAPS II
(41.0 ± 13.6 vs. 42.0 ± 11.7; p = 0.79) or ﬂuid balance.
ETT resistance increased from intubation to extubation:
from 6.8 ± 1.1 to 10.6 ± 4.3 cmH2OL
-1 s
-1 in the HH
group (p\0.001) and from 6.8 ± 1.1 to 10.2 ±
3.8 cmH2OL
-1s
-1 in the HME group (p\0.001).
Irrespective of the humidiﬁcation device there was a 53%
average increase in resistive load, suggesting a physio-
logical relevance.
Dead space and CO2 monitoring
The pathophysiological states of the lung result in an
increase in deadspace ventilation and thus in a reduced
ventilatory efﬁciency. A review article examined [20] the
current physiological concepts of deadspace and the
available methods to assess ventilatory efﬁciency at the
bedside. The Bohr and the Enghoff modiﬁcations of
Bohr’s equation were fully described, as well as the
Fowler’s method. The authors commented on several
indices that either predict deadspace or track ventilatory
efﬁciency at the bedside. They also described the various
clinical applications of deadspace measurements in the
critically ill patients.
Gancel et al. [21] tested a new transcutaneous CO2
monitor (TOSCA 500) in patients with acute respiratory
failure. Their ﬁnding was that the new tool compared well
with arterial CO2 measurements with a mean difference
of 0.1 mmHg for a range of values between 23 and
84 mmHg.
Diaphragm activity and gastroesophageal pressures
Barwing and co-workers [22] tested the efﬁciency of an
esophageal EMG catheter for assessing the diaphragm
electric activity. This is needed for guiding the ventilator
when providing NAVA. They found that PEEP, body
position and intra-abdominal pressure may affect the
catheter position and the EMG signal. This must be
realized when ﬁnding the optimal catheter position.
However, the authors conclude that they could always get
a stable EMG signal.
Demoule et al. [23] analyzed a technique to detect
phrenic nerve injuries since such injuries may cause
diaphragm dysfunction and impede ventilatory function.
They used cervical magnetic stimulation (CMS) to detect
a delayed or prolonged phrenic nerve conduction time and
compared it with electrical stimulation (ES) as a reference
technique. Their ﬁndings were that CMS compared well
with ES, making CMS an easy and reliable tool at the
intensive care unit.
545Chiumello and coworkers [24] tested the performance
of a new naso-gastric ‘‘polyfunctional’’ double-balloon
catheter with one balloon located in the esophagus and the
other in the stomach. The catheter performed reasonably
well compared with a standard balloon catheter and
should facilitate the simultaneous recording of esophageal
and intra-gastric pressures. One indication for its use is to
enable the distinction between pulmonary and extra-pul-
monary ARDS, but there are certainly many more where
abdominal pressure is of interest.
Sedation
Spies and colleagues [25] conducted a prospective, two-
center, randomized, triple-blind study involving adults
requiring mechanical ventilation (MV) for more than 24 h
aimed at comparing the quality of analgesia provided by a
remifentanil-based regime with that provided by a fenta-
nyl-based regime. Sedation was provided using propofol
(and/or midazolam if required). At planned interim
analysis (n = 60), 50% of remifentanil patients (n = 28)
and 63% of fentanyl patients (n = 32) had maintained
target analgesia scores at all time points (p = 0.44).
There were no signiﬁcant differences between the groups
with respect to mean duration of ventilation (135 vs.
165 h, p = 0.80), duration of hospital stay, morbidity or
weaning. Interim analysis strongly suggested futility, and
the trial was stopped. It was concluded that the use of
remifentanil-based analgesia in critically ill ventilated
patients was not superior to fentanyl-based analgesia.
Clouzeau et al. [26] assessed the feasibility and safety
of sedation with propofol target-controlled infusion dur-
ing ﬁberoptic bronchoscopy with bronchoalveolar lavage
in 23 hypoxemic patients undergoing NIV. Propofol tar-
get-controlled infusion allowed for good tolerance of the
procedure without causing any signiﬁcant adverse effects,
including endotracheal intubation (only one patient intu-
bated within 6 h after the procedure). These ﬁndings
encouraged the authors to perform an ongoing multicen-
tric study with the primary objective of determining if
using propofol target-controlled infusion during ﬁberoptic
bronchoscopy under NIV may prevent oxygenation
impairment and increase the clinical tolerance of the
procedure.
Physiological mechanisms
In an interesting review article Abreu and colleagues [27]
presented the recent advances in the ﬁeld of stem cell
biology, highlighting the effects of mesenchymal stem
cell therapy in the context of acute respiratory distress
syndrome, lung ﬁbrosis and chronic obstructive pulmon-
ary disease. Clinical and experimental studies published
in the past 11 years have been analyzed. The authors
found data suggesting beneﬁcial effects of mesenchymal
stem cells on lung development, repair and remodeling. A
number of studies reported that paracrine factors could be
effective in reducing inﬂammation and promoting tissue
repair. The mesenchymal stem cell releases several
growth factors and anti-inﬂammatory cytokines that reg-
ulate endothelial and epithelial permeability and reduce
the severity of inﬂammation. It was concluded that a
better understanding of the mechanisms that control cell
division and differentiation, as well as of their paracrine
effects, is required to enable the optimal use of bone
marrow-derived stem cell therapy to treat human respi-
ratory diseases.
Caironi and colleagues [28] hypothesized that the time
course of VILI may be fully explained from a single
perspective when considering the insult actually applied,
i.e., lung stress and strain. To test this hypothesis, a ret-
rospective analysis of data available in the literature was
performed. Studies in which healthy animals were
aggressively ventilated until preterminal VILI were
selected. Data on morphometry, ventilator settings,
respiratory function and duration of ventilation were
derived. For each animal group, lung stress (transpulmo-
nary pressure) and strain (end-inspiratory lung inﬂation/
lung resting volume ratio) were estimated. Twenty studies
including ﬁve mammalian species (sheep, pigs, rabbits,
rats and mice) were selected. Time to achieve preterminal
VILI varied widely (18–2,784 min), did not correlate with
either tidal volume or airway pressure applied, but was
weakly associated with lung stress (r
2 = 0.25,
p = 0.008). In contrast, the duration of mechanical ven-
tilation was closely correlated with both lung strain
(r
2 = 0.85, p\0.0001) and lung strain weighted for the
actual time of application during each breath (r
2 = 0.83,
p\0.0001), according to exponential decay functions. It
was concluded that lung strain may play a critical role as a
unifying rule describing the development of VILI among
mammals with healthy lungs. This article is accompanied
by an editorial comment by de Prost et al. [29].
Noninvasive ventilation
Several studies and reviews have been dedicated to the
clinical application of noninvasive ventilation (NIV).
Physiological studies
Fodil and colleagues [30] evaluated the role of interface
internal volume on the effective deadspace during NIV.
To better understand the effects of the geometrical design
of interfaces, the authors quantiﬁed ﬂow, pressure and gas
composition in terms of CO2 and O2 at the passage
through different types of interface (oronasal mask,
546integral mask and helmet). In particular, they postulated
that due to speciﬁc gas ﬂow passing throughout the
interface, the effective dead space added by the interface
is not always related to the whole gas volume included in
the interface. Numerical simulations, using computational
ﬂuid dynamics, were used to describe pressure, ﬂow and
gas composition during ventilation with the different
interfaces. Between the different interfaces the effective
dead spaces differed only modestly (110–370 ml),
whereas their internal volumes were markedly different
(110–10,000 ml). Effective dead space was limited to half
the tidal volume for the most voluminous interfaces,
whereas it was close to the interface gas volume for the
less voluminous interfaces, suggesting that effective dead
space is not related to the internal gas volume included in
the interface.
Cammarota and colleagues [31] published a study on a
short-term head-to-head physiologic comparison between
PSV and NAVA in delivering noninvasive ventilation
through a helmet (h-NIV) in patients with postextubation
hypoxemic acute respiratory failure. Ten patients under-
went three 20-min trials of h-NIV in PSV, NAVA and
PSV again. Arterial blood gases (ABGs) were assessed at
the end of each trial. Diaphragm electrical activity (EAdi)
and airway pressure (Paw) were recorded to derive neural
and mechanical respiratory rate and timing, inspiratory
(delayTR-insp) and expiratory trigger delays (delayTR-exp),
time of synchrony between diaphragm contraction and
ventilator assistance (timesynch), and the asynchrony index
(AI). Compared with PSV, with NAVA the mechanical
expiratory time was signiﬁcantly shorter, while the
inspiratory time and duty cycle were greater. Timesynch
was 0.79 ± 0.35 s in NAVA versus 0.60 ± 0.30 s and
0.55 ± 0.29 s during the PSV trials (p\0.01 for both).
AI exceeded 10% during both PSV trials, while not in
NAVA (p\0.001). The authors concluded that com-
pared with PSV, NAVA improves patient–ventilator
interaction and synchrony, with no difference in gas
exchange, respiratory rate, and neural drive and timing.
Milan et al. [32] tested different helmets for applying
continuous positive airway pressure (CPAP) and found
that large helmets with large anti-suffocation valves
minimized CO2 rebreathing during disconnection of the
fresh gas supply. The authors also emphasized the need of
monitoring and alarm systems to make the use of the
helmet as safe as possible.
Continuous positive airway pressure
The role for CPAP in acute cardiogenic pulmonary edema
(CPE) from out-of-hospital to cardiac intensive care unit
was evaluated by Ducros and colleagues [33] in a ran-
domized multicenter study on 207 patients that were
randomly allocated by emergency mobile medical units to
receive either standard treatment alone or standard
treatment plus CPAP. CPAP was maintained after
admission to the ICU. Inclusion criteria were orthopnea,
respiratory rate greater than 25 breaths/min, pulse oxim-
etry less than 90% in room air and diffuse crackles. The
primary endpoint was assessed during the ﬁrst 48 h and
combined death, presence of intubation criteria, persis-
tence of either all inclusion criteria or circulatory failure
at the 2nd hour or their reappearance before 48 h.
Absence of all criteria deﬁned successful treatment.
CPAP was used for 60 min in the pre-hospital setting and
120 min in the ICU, and was well tolerated in all patients.
Treatment was successful in 79% of patients in the CPAP
group and 63% in the control group (p = 0.01), especially
for persistence of inclusion criteria after 2 h and for
intubation criteria. CPAP was beneﬁcial irrespective of
the initial PaCO2 or left ventricular ejection fraction,
suggesting that immediate use of CPAP in out-of-hospital
treatment of CPE and until CPE resolves after admission
signiﬁcantly improves early outcome compared with
medical treatment alone.
Noninvasive pressure support ventilation (NIPSV) and
CPAP are indeed both used as supportive treatment for
CPE. Nouira and colleagues [34] hypothesized that
NIPSV would be better than CPAP in terms of clinical
beneﬁt. They conducted a prospective, randomized, con-
trolled study in 200 patients (CPAP 101 patients and
NIPSV 99 patients). The primary outcome was combined
events of hospital death and tracheal intubation. They
found a hospital mortality of 5.0% for NIPSV and 2.9%
for CPAP (p = 0.56). The need for intubation was 6%
patients in the NIPSV group and 3.9% in the CPAP group
(p = 0.46). It was concluded that CPAP does not affect
primary clinical outcome in patients with CPE. This
article is accompanied by an editorial comment [35].
Cammarota et al. [36] compared different regimes of
non-invasive ventilatory support by a Venturi mask or by
CPAP in patients with hypoxemic respiratory failure due
to either unilateral or bilateral lung involvement. The
authors found that CPAP with a pressure of 10 cmH2O
was better in oxygenating blood than breathing with a
Venturi mask and also normalized PaCO2 in patients with
bilateral affection. Adding a sigh (25 cmH2O for 8 s)
improved further oxygenation in bilateral but not in uni-
lateral lung involvement. Thus, recruitment maneuvers
may be useful also during CPAP if there is a bilateral lung
affection.
Speciﬁc settings of application
Postoperativepulmonarycomplications occur in5–10%of
allsurgicalpatients.Chiumelloandcolleagues[37]carried
out a systematic review to determine the efﬁcacy of NIV
versus standard therapy to treat or prevent postoperative
pulmonary complications. Twenty-nine randomized con-
trolled trials were analyzed. Noninvasive ventilation
547improved arterial blood gases in 15 of the 22 prophylactic
and in 4 of the 7 therapeutic studies; it also reduced the
intubation rate in 11 of the 29 studies, and improved out-
come in only 1. It was concluded that early administration
of noninvasive ventilation could be considered as a pro-
phylactic and therapeutic tool to improve gas exchange in
postoperative patients.
Noninvasive ventilation NIV is increasingly used as a
palliative strategy when endotracheal ventilation is
deemed inappropriate. In this context, palliative NIV can
either be administered to offer a chance for survival or to
alleviate the symptoms of respiratory distress in dying
patients. However, the implementation of palliate nonin-
vasive ventilation remains a controversial issue. In the
August issue a review on this subject was published [38]
that analyzed ten studies published between 1992 and
2006, including 458 patients who received palliative NIV.
The authors found that the technique was feasible, usually
well tolerated and half of the patients survived. The
potential beneﬁts and harm from noninvasive ventilation
in patients who are not eligible for endotracheal ventila-
tion are also discussed. It was concluded that the use of
palliative noninvasive ventilation is recognized, but
qualitative data (patient comfort, end-of-life process,
family burden and health-care provider satisfaction) are
still insufﬁciently reported.
Noninvasive ventilation is an interesting option to
avoid reintubation in patients at risk for extubation fail-
ure. In this kind of patient, Dimassi et al. [39] compared
the short-term physiologic effects of NIV and intrapul-
monary percussive ventilation (IPV), a high-frequency
ventilation modality that can be superimposed on spon-
taneous breathing and has the potential to decrease
respiratory muscle loading. As compared to spontaneous
breathing, indexes of diaphragmatic effort (transdia-
phragmatic pressure and the pressure-time product of the
diaphragm) and respiratory rate decreased with both NIV
and IPV. IPV was, however, less effective than NIV in
improving alveolar ventilation.
Oxygen therapy
Two articles dealt with oxygen administration in critically
ill patients. In the ﬁrst, De Graaff et al. [40] retrospec-
tively evaluated 126,778 arterial blood gas data from
5,498 mechanically ventilated patients and assessed cli-
nicians’ response to hyperoxia (PaO2 [120 mmHg).
Hyperoxia occurred frequently (22% of arterial blood
gases), but FiO2 was decreased in only 25% of cases. In
particular, ventilator settings were not modiﬁed when
FiO2 was B0.4. This article was accompanied by an
editorial by Branson [41]. In the second paper, Sztrymf
et al. [42] evaluated the efﬁcacy and safety of nasal high
ﬂow oxygen therapy in 38 adult, spontaneously breathing
patients with hypoxemic acute respiratory failure. Nasal
high ﬂow oxygen was well tolerated and improved oxy-
genation while decreasing respiratory rate, heart rate and
dyspnea. In nine patients nasal high ﬂow oxygen failed
and endotracheal intubation was required; these patients
had a higher respiratory rate, lower oxygenation and
persistence of thoraco-abdominal asynchrony. According
to the authors, these results provide sufﬁcient data to
launch a randomized controlled study to investigate
whether nasal high ﬂow oxygen therapy reduces intuba-
tion in patients with hypoxemic acute respiratory failure.
Pediatrics
PICU organization and outcomes
Randomized clinical trials in pediatric critical care are
frequently difﬁcult to establish and complete, for reasons
that include the relatively small number of children who
become critically ill. High-value data that have the
potential to change practice are, however, increasingly
available through the interrogation of large pediatric
critical care databases and registries such as the Dutch
Pediatric Intensive Care Evaluation registry and the UK
PICANET registry (www.picanet.org.uk). Visser and
colleagues [43] identiﬁed all infants admitted to Dutch
pediatric intensive care units over a 4-year period with
conﬁrmed diagnoses of intracranial bleeding due to vita-
min K deﬁciency (VKDB), demonstrating superior case
detection than that achieved with the existing standard
surveillance system. The study demonstrated clearly the
potential usefulness of the PICE registry, and by inference
other large national registries, in monitoring the ongoing
incidence of speciﬁc conditions, including relatively rare
conditions such as VKDB. Such ongoing surveillance-
associated analysis has the potential to provide evidence
of changing outcomes as new clinical treatments or care
pathways are introduced especially in areas where con-
ventional clinical trials may prove difﬁcult or unweildy.
While the application of information technology (IT) in
health care is often assumed to be innovative and there-
fore to ‘improve’ care, this is not always the case. It is,
however, increasingly evident that careful design and
implementation of IT-based systems can confer sub-
stantial beneﬁts in some areas of patient care. In pediatric
critical care, drug prescription is complex due to the need
for multiple dose calculations based on weight or surface
area electronic prescribing systems (EPS) with high-level
decision support, have the potential to reduce prescribing
and errors, and are effective in ensuring planned drug
doses are administered as recently demonstrated by
Warrick et al. [44]. While single-center studies of IT-
based critical care innovations are of limited value, as
with large ‘national’ databases, larger scale studies
incorporating standardized data sets and deﬁnitions have
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clinical or ﬁnancial beneﬁt, therefore providing a solid
foundation for the diffusion of the IT into the wider
health-care community. Collaborative approaches to IT-
led improvement in pediatric critical care can only be
strongly encouraged.
Brown et al. [45] evaluated the match or mismatch
between workload in a pediatric intensive care unit and
the medical stafﬁng levels available over 24-h periods.
Key events included in the evaluation were admissions,
severity of illness on admission, cardiac arrests and
ECMO cannulations. One of their key ﬁndings was that
there was an increase in the adjusted risk of death for
admissions occurring between 2000 and 0159 h, at a time
when lower concentrations of staff were available and
patients admitted had higher Pediatric Index of Mortality
2 scores. While much of the information gained from this
study is mainly of local interest there is a clear message: a
simple evaluation such as this can be used to identify
deﬁciencies in stafﬁng structures in an objective manner
and used to inform construction of stafﬁng models aimed
at better matching patient ﬂows and acutity, thereby
improving patient safety and outcomes.
The vast majority of children admitted to PICUs are
neonates or infants, so standard follow-up ‘patient satis-
faction’ surveys used in adult care cannot be used.
Parents’ experiences of pediatric intensive care are
important not only in assessing ‘satisfaction’ with their
opinions about the care of their children, but also their
more deeply lived experiences as parents living through
the often traumatic and emotional experince of their
children’s critical illness. Two papers from Latour and
colleagues [46, 47] have recently added to our knowledge
in this important aspect of care. Firstly Latour and col-
leagues sought to investigate the in-depth experiences of
parents during the admission of their child to one of seven
participating Dutch PICUs. Thirty-nine mothers, 25
fathers and 41 children were interviewed 1 month after
their child’s discharge from the PICU. Thematic analysis
was used to sort quotations from these interviews into
sub-themes and further into main themes: attitude of
professionals, coordination of care, emotional intensity,
information management, environmental factors and
parent’s participation in care. This study identiﬁed key
areas of importance, which Latour and colleagues then
used to develop and psychometrically test a questionnaire
(the EPATHIC questionnaire) to measure parent satis-
faction. The construction and testing involved input from
2,046 parents from 8 Dutch pediatric intensive care units,
addressing questions within 5 domains: information, care
and cure, organization, parental participation and staff
attitude. The ﬁnal questionnaire emerged with 65 state-
ments after rigorous content, validity and performance
against embedded ‘gold standard’ questions. Although
well validated in a Dutch population, this questionnaire
will require further testing and possible modiﬁcation if it
is to be used in different populations. These studies
highlight the huge emotional complexity of pediatric
critical illness for parents as well as children, and the rigor
needed to develop meaningful tools to assess ‘satisfac-
tion’ in such a complex care pathway.
Cardiopulmonary resuscitation
Unlike adults, asphxia is a common cause of cardiac
arrest in children, although few data are available on its
evolution and resolution. Lopez-Herce used an infant
animal model of asphyxial cardiac arrest to follow the
evolution of cardiopulmonary arrest in 71 anesthetized
infant piglets following cessation of ventilation [48].
During asphyxia severe arterial and tissue hypoxia,
hypercapnia and lactic acidosis developed rapidly. Bra-
dycardia, hypotension, and increasing PVR and SVR
were observed. During CPR arterial, cerebral and tissue
oxygenation and hemodynamic parameters were rapidly
corrected with return of spontaneous circulation. A fur-
ther study from the same group [49] compared outcomes
from asphyxial cardiac arrest in a similar infant piglet
model. Piglets were randomized to receive either con-
tinuous chest compressions and non-coordinated
ventilation or chest compressions alone. Nine minutes of
basic resuscitation was completed in both groups of pig-
lets followed by standard advanced resuscitation
measures for up to a total of 30 min. Although neither of
the basic CPR protocols achieved adequate oxygenation
and ventilation, piglets in the ventilation group had better
blood gas and cerebral oxygenation parameters than those
in the CPR-only group. Resuscitation in infants and
children is importantly different in many respects from
adult resuscitation. Although ﬁrm recommendations for
improved resuscitation techniques for children cannot be
drawn directly from these two studies alone, they con-
tribute importantly to the scientiﬁc literature on pediatric
resuscitation literature and will certainly inform further
studies and analyses. The use of ECMO during pediatric
resuscitation has been increasingly reported [50] and
enthusiastically adopted in many centers. Nevertheless, it
has become increasingly apparent that the duration of
CPR prior to the commencement of ECMO is an impor-
tant factor in determining patient outcomes, with lower
survival [51] and higher risk of poorer neurological out-
comes (Sivarajan VB et al. ICM 2011) being associated
with longer pre-ECMO resuscitation times.
Cardiovascular topics
There is increasing interest in the use of sildenaﬁl in the
treatment of neonatal and pediatric diseases with associ-
ated pulmonary hypertension [52, 53]. Until recently, the
lack of a suitable intravenous preparation of the drug has
549restricted the ability of intensivists to evaluate its use in
the sickest children. Fraisse et al. [54] have recently
published a preliminary report of the use of IV sildenaﬁl
in children with pulmonary hypertension following sur-
gical repair of congenital heart disease. Although the
study was heavily underpowered, the use of IV sidenaﬁl
was associated with reduced pulmonary artery pressures
and shortened time to extubation. These ﬁndings alone are
insufﬁcient to support recommendations of routine use of
IV sildenaﬁl in clinical practice, but should encourage
further exploration of the drug in pediatric and neonatal
applications.
Hebbar and colleagues [55, 56] published two
important papers in 2011 related to the use of cortico-
steroid management in shock. In their ﬁrst paper, the
authors investigated the incidence of absolute and relative
adrenal insufﬁciency in a retrospective study of 78 chil-
dren with SIRS and vasopressor-dependent shock. They
determined that absolute and relative adrenal insufﬁ-
ciency was prevalent in this cohort of children and that its
incidence increased with age. Introduction of steroids was
associated with a signiﬁcant reduction in vasopressor
duration and dosage, and the authors hypothesized that
low-dose adrenocorticotropin testing may help further
delineate populations of children with shock who require
steroid supplementation. In this journal, the authors added
to these ﬁndings by reviewing a retrospective cohort of 97
children with SIRS and shock to determine the effect of
adding ﬂudrocortisone (FLU) to hydrocortisone (HC)
treatment. Fifty-two percent of the children included met
deﬁntions for sepsis. Septic children who received
HC ? FLU required vasopressor support for signiﬁcantly
shorter durations than those who received HC alone
(p = 0.011). As in adults, the debate on if or when, in
whom and with what to supplement endogenous steroids
in children with shock states continues to rage. High-
quality randomized clinical trials are needed here.
Two studies published in the journal during 2011
explore innovative monitoring applications in pediatric
critical care. In a small study, Kuhlwein et al. [57] pro-
spectively studied ventilation-induced arterial and central
venous pressure variations in a group of 20 critically ill
children. This preliminary study identiﬁed that increasing
peak inspiratory pressure signiﬁcantly increased ventila-
tion-induced variations in systolic pressure, pulse pressure
and central venous pressure. As ventilation-induced
variations in arterial pressure have been shown to predict
volume responsiveness in critically ill adults, similar
studies of this concept in children are eagerly awaited.
Teng et al. [58] assessed an adult-approved continuous
ﬂow monitoring device, the Flo Trac/Vigileo (Edwards
Life Sciences), in children, comparing the device against
pulmonary artery catheter-derived thermodilution cardiac
output measureents. One hundred thirty-six comparisons
were studied in 36 children ranging in age between
months and 16 years in whom the two devices were
deployed; all had diagnoses of either cardiomyopathy or
pulmonary hypertension. There was poor agreement
between PAC and Flo Trac measurements, and therefore
the utility of the Flo Trac in children remains uncertain.
As the beneﬁts of goal-directed therapeutic impact of ﬂow
measurements in children are themselves disputed, further
developments in this ﬁeld are keenly awaited.
Nosocomial infection
Central venous catheters (CVCs) are widely used in
critical care; 238,000 are estimated to be inserted each
year in the UK [59]. CVCs are associated with an
increased risk of nosocomial blood stream infection
(BSI), which is acknowledged to be an important cause of
mortality, morbidity, increased length of stay and sub-
stantial extra costs for pediatric patients [60, 61]. Ahead
of a multicenter randomized-controlled trial, Harron et al.
undertook a survey of all UK pediatric intensive care
units to determine which of eight interventions commonly
adopted to lower the incidence of CR–BSI were in use
and explored whether lack of child-speciﬁc evidence
explained variances. They uncovered widespread varia-
tions in practice, which were at least in part explained by
the lack of evidence from pediatric studies on important
issues including the safety and efﬁcacy of chlorhexidine
skin preparations in young children. They recommended
that national or international guidelines on the prevention
of CR-BSI should speciﬁcally address issues relevant to
pediatric practice, supporting these with reports of the
quality of evidence and the strength of the recommen-
dations based upon them. Rey et al. [62] reported on
factors inﬂuencing the occurrence of CR-CBSI from a
large propsectively studied cohort of critically ill children.
They reduced their CR–BSI rate from 11.94 per
1,000 catheter days to 3.05 per 1,000 catheter days when
measures to limit insertion times and measures to reduce
the use of parenteral nutrition were introduced to sup-
plement standard insertion and care guidelines. Roeleveld
[63] reported on the prevalence of ventilator-associated
pneumonia (VAP) in children following cardiac surgery.
The incidence of VAP detected was 1.7 per 1,000 venti-
lator days, a higher ﬁgure than has been reported in
general PICU populations [64]. The only independent
factor associated with the onset of VAP was a higher
severity of illness score (PRISM III[10). It remains to be
shown from other studies whether children following
cardiac surgery are at greater risk of developing VAP or
whether this result simply reﬂects local or other unex-
plored factors.
Immunoparalysis, deﬁned by prolonged monocyte
human leukoycte antigen DR depression, is associated
with adverse outcomes in adult sepsis. Hall et al. [65]
performed a multicenter cohort trial of children with
multi-organ dysfunction syndrome (MODS). In phase 1 of
550their study, they determined that immunoparalysis
occurred in 34% of the 70 MODS children. In a second
study period nonneutropenic, nontransplant patients with
dysfunction of[3 organs and with ex vivo LPS-induced
TNFa response \160 pg/ml on day 3 of MODS were
eligible for enrollment in a prospective, randomized,
open-label GM-CSF study, a factor that has been shown
to revere immunoparalysis in adult sepsis. All seven of
the children receiving standard care developed nosoco-
mial infection with 2/7 deaths. In contrast, the seven
children randomized to GM–CSF therapy showed
reversed immunoparalysis in\7 days and experienced no
nosocomial infections (p\0.05) or deaths. No GMCSF-
related adverse events were observed. This small open-
label study appears to offer the prospect of a powerful
intervention for critically ill children with severe sepsis,
but its potential usefulness needs to be addressed in
carefully conﬁgured randomized controlled trials.
Sedation and analgesia
Delirium is probably underdiagnosed and is a poorly
understood problem in pediatric intensive care. Janssen
and colleagues [66] explored the validity of using the
pediatric anesthesia emergence dilrium (PAED) scale,
DRSR-98 and DRS-88 scales in a PICU setting. They
found that only the PAED instrument performed well in
the assessment of delirium in critically ill children against
a clinical gold standard, a structured neuropyschiatric
assessment. Now that a suitable assessment tool is
available for the assessment of delirium in critically ill
children, further studies of its management and preven-
tion are urgently needed. Dexmedetomidine, a selective
alpha-2 adrenergic receptor agonist, exhibits potent sed-
ative, anxiolytic and mild analgesic effects without
respiratory depression [67]. Its use in adult critical care
has recorded several apparent beneﬁts including opioid
and benzodiazepine-sparing effects, and a reduced inci-
dence of delirium and withdrawal syndromes. Its use in
children is less well established, although early reports
suggest that it may confer similar beneﬁts to those seen in
adults [68]. The report published recently in the journal
from Le and colleagues [69] disappointingly failed to
demonstrate any beneﬁt from the addition of dexmede-
tomidine to standard peri-operative sedative–analgesic
agents in children undergoing cardiac surgery. Although
relatively large numbers of children were studied, the
retrospective sequential cohort design of this study is a
major weakness, as is its failure to formally assess the
incidence of delirium and the occurrence of haemody-
namic side effects such as hypotension and bradycardia.
Despite this negative report, dexedetomidine is, as others
have shown, of great interest to pediatric intensivists, but
requires further study.
Respiratory disease and respiratory support
Respiratory failure and respiratory support are recognized
as the key element of all critical care, be it for newborns,
infants, children, teenagers or adults. The journal is for-
tunate to continue to attract excellent papers from
neonatology. Two recently published studies illustrate
both the value and the challenges of studies in the sick
neonate. Tsapis undertook a study to determine the
threshold value between normal and reduced dynamic
compliance (Cdyn) in ventilated near-term newborns
using the algorithm built into their neonatal ventilator
(Draeger 8000plus). A population of 30 newborns without
pulmoanry disease and 30 with respiratory distress syn-
drome was studied. Receiver-operating characteristic
curves for height-adjusted Cdyn were contructed. A cutoff
value of 2.02 ml/mbar.m was determined (sensitivity
100%, speciﬁcity 96%) to differentiate between normal
and decreased lung compliance. The validation of venti-
lator-derived values under ﬁeld conditions supports the
use of similarly derived compliance data in the clinical
management of the ventilated newborn [70]. Cogo and
colleagues [71] report on the need for re-dosing with
surfactant in preterm newborns, linking surfactant kinetics
to clinical and respiratory parameters. Although not
reported in this study, it is logical to speculate that the
measurement of dynamic compliance described by Tsapis
would be a worthwhile parameter to follow in preterm
neonates potentially requiring surfactant re-dosing.
Recent years have seen the expansion of respiratory
support options for patients of all ages. Several papers
published in the journal in 2011 related to the application
of use of noninvasive respiratory support in children
in situations where traditional management would have
been invasive ventilation. Williams and colleagues [72]
described the use of bi-level positive airway pressure
(BiPAP) started in the emergency department in children
\20 kg with acute exacerbations of asthma. Their report
covered 165 children with moderate or severe asthma. No
patients died, and none exhibited worsening hypoxia or
pneumothorax. Sixty percent were admitted to the PICU
where BiPAP continued for a mean of 6.6 h (range
0–47 h). The authors conclude that the use of BiPAP in
the emergency management of acute asthma warrants
further prospective investigation. James and colleagues
[73] reviewed the case records of 83 children who com-
menced NIV in an attept to avoid intubation, of whom
only 36% required intubation. Failure of NIV was inde-
pendently associated with higher respiratory rates before
commencement of NIV. Patients with respiratory diag-
noses were more likely to be successfully supported with
NIV than patients with oncologic disease, especially those
with sepsis. The report of Piastra [74], showing that the
number of failing organs predicts failure of NIV, is con-
sistent with the report of James and adds further depth to
551knowledge in this expanding area of interest [75].
Although NIV technologies in many indications are rel-
atively recent, its usefulness in bronchiolitis has been
accepted, although relatively poorly supported by high
quality studies. The reports of Essouri and Schibler pro-
vide good contemporary evidence for the use of nasal
continuous positive airway pressure (nCPAP), Essouri
[76] showing that a level of nCPAP of 7 cmH2O provides
optimal off-loading of respiratory muscles, with Schibler
[77] demonstrating that a high-ﬂow nasal cannula system
was successful in avoiding ventilation in 4% of a group of
infants with bronchiolitis.
The mechanisms of neonatal and childhood critical
lung diseases are difﬁcult to study for logistical and
sometimes ethical reasons. Meconium aspiration syn-
drome (MAS) is a life-threatening peri-natal inﬂammatory
lung condition. Pancreatic secretory phospholipase A2
(sPLA2-lB) and proinﬂammatory cytokines are believed
to be central in the genesis of MAS. De Luca and col-
leagues [78] undertook a study of speciﬁc phospholipases
and their modulators in broncho-alveolar lavage ﬂuid and
meconium from 5 control neonates and 5 babies with
meconium aspiration syndrome, and showed that locally
produced pulmonary phospholipase (sPLA2) contributes
to total phospholipase activity during MAS. Lubrano [79]
reported on the prognostic value of the extravascular lung
water index (EVLWI) in critically ill children with acute
respiratory failure, and its relationship to indices of oxy-
genation and ventilation. Children with lower EVLWI on
admission and a fall in EVLWI in the ﬁrst 24 h of
admission were associated with survival. As a survival
indicator, EVLWI measured by the PiCCO device (Pul-
sion Medical Systems) displayed good sensitivity and
speciﬁcity, and correlated well with indices of oxygena-
tion, ﬂuid overload and pulmonary permeability. Whether
in fact routine measurement of EVLW is useful in guiding
the assessment and ﬂuid replacement therapy in children
with ARF has yet to be determined.
Borik [80] reported an elegant study to test the
hypothesis that RNA editing is altered in children with
cyanotic congenital heart disease, and to determine
whether adenosine-to-inosine RNA is correlated to a
child’s postoperative clinical course. The authors have
previously shown the occurrence of changes in A-to-I
RNA editing in a cell line subjected to hypoxic conditions
[81]. The key ﬁndings of their recent report in the journal
are that cyanotic heart disease is associated with higher
rates of A-to-I RNA editing than acyanotic children.
Adjustments that follow hypoxia take place on several
planes, including increased ventilation and cardiac output,
a switch to anaerobic metabolism, improved vasculari-
zation and enhanced oxygen-carrying capacity by
hemoglobin. Thus, it is possible that the epigenetic pro-
cess of A-to-I RNA editing is also involved on various
levels of cellular adaptation to cyanosis.
Renal and metabolic
The great debate surrounding the management of glyce-
mia in the critically ill continues unabated. A report from
Hill eloquently describes the pitfalls of blood glucose
measurement in pediatric critical care and their implica-
tions for clinical trials of glucose control. Importantly, the
authors stress that inaccurate measurements may mask
hypoglycemia, and therefore obscure or prevent any
potential beneﬁt from control of glycemia emerging from
a clinical trial [82].
Finally, the difﬁculty of deﬁning and quantifying ﬂuid
overload in pediatric critical illness is addressed by Sel-
ewski [83]. In a simple study the authors showed that both
weight-based and ﬂuid balance-based methods of quan-
tifying ﬂuid overload were valid in their look-back cohort
of children undergoing continuous renal replacement
therapy (CRRT).
Miscellanea
Carlesso et al. [84] analyzed, with the help of a mathe-
matical model, the effect of diluting human plasma with
crystalloid solutions that have strong ion difference (SID).
Their ﬁndings were that the baseline bicarbonate con-
centration will determine the pH response to crystalloid
infusion. Thus, if the crystalloid equals baseline bicar-
bonate concentration, pH will not be altered at constant
PCO2, whereas it decreases if the SID is grater and
decreases if SID is lower than baseline bicarbonate.
In an observational study, Bonizzoli et al. [85] eval-
uated the rate of thrombosis associated with peripherally
inserted central venous catheters (PICC) and central
venous catheters in patients discharged from the ICU.
Patients with PICC (n = 114) had a signiﬁcantly higher
incidence of deep venous thrombosis than patients with
central venous catheters (n = 125) (27 vs. 10%), the
majority of thrombosis occurring within 2 weeks after
PICC insertion. Female gender and access through the left
basilic vein were associated with a higher risk of throm-
bosis in the PICC group. The authors concluded that, in
patients discharged from the ICU, routine ultrasound
surveillance for the ﬁrst 2 weeks after PICC insertion and
preferential use of central venous catheters may be
warranted.
De Keulenaer and coworkers [86] investigated whe-
ther intra-abdominal pressure (IAP) assessed by the
urinary bladder pressure correlated well with femoral
venous pressure in 149 critically ill, mechanically venti-
lated patients. The bias between IAP and femoral venous
pressure was -1.5 and precision was 3.6 mmHg, with
large limits of agreement (-8.6 and 5.7). When IAP was
above 20 mmHg, bias was 0.7 with a precision of
5522.0 mmHg (lower and upper limits of agreement of -3a n d
4.6, respectively). Excluding patients with abdominal
compartment syndrome, a femoral venous pressure of
11.5 mmHg predicted intra-abdominal hypertension with a
sensitivity of 85% and a speciﬁcity of 67%. The authors’
conclusions were that femoral venous pressure cannot be
recommended as a surrogate measure for IAP measure-
ment via the bladder, unless IAP is above 20 mmHg.
In a multicenter cohort study including data from
8,962 critically ill patients, Ho and coworkers [87]
assessed whether the intensity of smoking history has a
dose-related effect on hospital mortality. Smokers were
more frequently male and had a higher incidence of
severe chronic cardiovascular, respiratory and liver dis-
eases. The risk of requiring mechanical ventilation and
dying in hospital was higher and ICU stay was longer in
smokers than in non-smokers. After adjusting for other
confounders, intensity of smoking history (measured in
pack-years) remained signiﬁcantly associated with hos-
pital mortality in a relatively linear fashion.
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